Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | INCA033989 |
Trade Name | |
Synonyms | INCA-033989|INCA 033989 |
Drug Descriptions |
INCA033989 is a monoclonal antibody targeting mutant CALR, which inhibits downstream signaling and potentially decreases cell proliferation (Blood (2022) 140 (Supplement 1): 14-15). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
INCA033989 | INCA033989 | 0 | 2 |
INCA033989 + Ruxolitinib | INCA033989 Ruxolitinib | 0 | 1 |